The Food and Drug Administration is asking for public comment on a new Web portal it is developing to collect and analyze drug information.
The portal would allow the agency to electronically collect all adverse-event data, consumer complaints, product problems and medication errors through one central location. Streamlining data collection through the portal, dubbed the MedWatch portal, will improve the agencys ability to manage drug event reporting, the FDA said in the Oct. 23 Federal Register. In addition, FDA participants who are mandated to submit reports on adverse events and drug errors will be able to do so through the portal, and anyone else who would like to submit a report can use the portals online questionnaire to guide them.
Comments on the portal must be submitted by Dec. 22.